Tetrahydroaminoacridine improves the recency effect in Alzheimer's disease

Neuroscience

Volumn 83, Issue 2, 1998, Pages 471-479

  Riekkinen, M ^a   Soininen, H ^a   Riekkinen Sr , P ^b   Kuikka, J ^a   Laakso, M ^a   Helkala, E L ^b   Partanen, J ^a   Riekkinen Jr , P ^a  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Atrophy; Hippocampus; List learning; MRI; Prefrontal cortex; SPECT

Indexed keywords

TACRINE;

ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CORRELATION FUNCTION; DRUG EFFECT; HUMAN; MEMORY; PRIORITY JOURNAL; SENILE PLAQUE;

AGED; ALZHEIMER DISEASE; AMYGDALA; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; CEREBROVASCULAR CIRCULATION; CHOLINESTERASE INHIBITORS; CYSTEINE; FEMALE; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MEMORY, SHORT-TERM; PARASYMPATHETIC NERVOUS SYSTEM; SENILE PLAQUES; TACRINE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0031929076     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(97)00400-4     Document Type: Article

References (32)

1. Bowen D. M., Allen J. S., Benton S. J., Goodhart M. J., Haan E. A., Palmer A. M., Sims N. R., Smith C. C. T., Spillane J. A., Esira G. K., Neary D., Snowden J. S., Wilcock G. K. and Davison A. N. (1983) Biochemical assessement of serotonergic and cholinergic dysfunction and cerebral atrophy in Alzheimer's disease. J. Neurochem. 41, 266-272.
2. Bowen D. M., Smith C. B., White P. and Davison A. N. (1976) Neurotransmitter related enzymes and indices of hypoxia in senile dementia and other abiotrophies. Brain 99, 459-496.
3. Braak H. and Braak E. (1996) Evolution of the neuropathology of Alzheimer's disease. Acta. neural. scand. 165 Suppl., 3-12.
4. Bunsey M. and Eichenbaum H. (1993) Critical role of the parahippocampal region for paired-associate learning in rats. Behav. Neurosci. 107, 740-747.
5. Drachman D. A. and Sahakian B. (1979) Effects of cholinergic agents on human learning and memory. In Nutrition and the Brain, Vol. 5, pp. 351-356. Raven, New York.
6. Dunnett S. B., Barry J. E. and Robbins T. (1991) The basal forebrain-cortical cholinergic system: interpreting the functional consequences of excitotoxic lesions. Trends Neurosci. 14, 494-501.
7. Eichenbaum H., Otto T. and Cohen N. J. (1994) Two functional components of the hippocampal memory system. Behav. Brain Sci. 17, 449-518.
8. Eslinger P. J. and Grattan L. M. (1994) Altered serial position learning after frontal lobe lesion. Neuropsychologia 32, 729-739.
9. Fray P., Robbibs T. and Sahakian B. (1996) Neuropsychiatric applications of Cantab. Int. J. geriat. Psychiat. 11, 329-336.
10. Gaffan D. (1994) Dissociated effects of perirhinal cortex ablation, fornix transection and amygdalectomy: evidence for multiple memory systems in the primate temporal lobe. Expl Brain Res. 99, 411-422.
11. Kar S., Seto D., Gaudreau P. and Quirion R. (1996) Beta-amyloid-related peptides inhibit potassium-evoked acetylcholine release from rat hippocampal slices. J. Neurosci. 16, 1034-1040.
12. Kelly J. M., Furukawa K., Barger S. W., Rengen M. R., Mark R. J., Blanc E. M., Roth G. S. and Mattson M. P. (1996) Amyloid β-peptide disrupts carbachol-induced muscarinic cholinergic signal transduction in cortical neurons. Proc. natn. Acad. Sci. U.S.A. 93, 6753-6758.
13. Knapp M. J., Knopman D. S., Solomon P. R., Pendlebury W. W., Davis C. S. and Gracon S. I. (1994) A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. The Tacrine Study Group [see comments]. . J. Am. med. Assoc. 271, 985-991.
14. Laakso M., Soininen H., Partanen J., Helkala E.-L., Hartikainen P., Vainio P., Hallikainen M., Hänninen T. and Riekkinen P. S. (1995) Volumes of hippocampus, amygdala and frontal lobes in the MRI-based diagnosis of early Alzheimer's disease: correlation with memory functions. J. neural Transm. 9, 73-86.
15. Lawrence A. D. and Sahakian B. J. (1995) Alzheimer disease, attention, and the cholinergic system. Alzheimer. Dis. Assoc. Disord. 2 Suppl. 9, 43-49.
16. Muir J. L., Everitt B. J. and Robbins T. W. (1994) AMPA-induced excitotoxic lesions of the basal forebrain: a significant role for the cortical cholinergic system in attentional function. J. Neurosci. 14, 2313-2326.
17. Poirier J. (1994) Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease. Trends Neurosci. 17, 525-530.
18. Poirier J., Delisle M. C., Quirion R., Aubert I., Farlow M., Lahiri D., Hui S., Bertrand P., Nalbantoglu J. and Gilfix B. M. (1995) Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease.. Proc. natn. Acad. Sci. U.S.A. 92, 12260-12264.
19. Polvikoski T., Sulkava R., Haltia M., Kainulainen K., Vuorio A., Verkkoniemi A., Niinistö L., Halonen P. and Kontula K. (1995) Apolipoprotein E, dementia, and cortical deposition of β-amyloid protein. New Engl. J. Med. 333, 1242-1247.
20. Riekkinen M. and Riekkinen P. Jr (1997) Dorsal hippocampal muscarinic acetylcholine and NMDA receptors disrupt water maze navigation. NeuroReport 8, 645-648.
21. Riekkinen P. Jr, Kuikka J., Soininen H., Helkala E.-L., Hallikainen M. and Riekkinen P. Sr (1995) Tetrahydroaminoacridine modulates technetium-99m labelled ethylene dicysteinate retention in Alzheimer's disease measured with single photon emission computed tomography imaging. Neurosci. Lett. 195, 53-56.
22. Riekkinen P. Jr, Soininen H., Helkala E.-L., Partanen K., Laakso M., Vanhanen M. and Riekkinen P. Sr (1995) Hippocampal atrophy, acute THA treatment and memory in Alzheimer's disease. NeuroReport 6, 1297-1300.
23. Riekkinen P. Jr, Soininen H., Partanen J., Pääkkönen A., Helisalmi S. and Riekkinen P. Sr (1997) The ability of THA treatment to increase cortical alpha waves is related to apolipoprotein E genotype of Alzheimer disease patients. Psychopharmacology 129, 285-288.
24. Robbins T. W., Elliott R. and Sahakian B. (1996) Neuropsychology-dementia and affective disorders. Br. med. Bull. 52, 627-643.
25. Sahakian B. J., Owen A. M., Morant N. J., Eagger S. A., Boddington S., Crayton L., Crockford H. A., Crooks M., Hill K. and Levy R. (1993) Further analysis of the cognitive effects of tetrahydroaminoacridine (THA) in Alzheimer's disease: assessment of attentional and mnemonic function using CANTAB. Psychopharmacology, Berlin 110, 395-401.
26. Soininen H. S., Karhu J., Partanen J., Paakkonen A., Jousmaki V., Hanninen T., Hallikainen M., Partanen K., Laakso M. P. and Koivisto K. (1995) Habituation of auditory N100 correlates with amygdaloid volumes and frontal functions in age-associated memory impairment. Physiol. Behav. 57, 927-935.
27. Soininen H., Kosunen O., Helisalmi S., Mannermaa A., Paljärvi L., Talasniemi S., Ryynänen M. and Riekkinen P. Sr (1995) A severe loss of choline acetyltransferase in the frontal cortex of Alzheimer patients carrying apolipoprotein E4 allelle. Neurosci. Lett. 187, 79-82.
28. Soininen H., Partanen K., Pitkänen A., Hallikainen M., Hänninen T., Helisalmi S., Mannermaa A., Ryynänen M., Koivisto K. and Riekkinen P. Sr (1995) Decreased hippocampal volume asymmetry on MRIs in nondemented elderly subjects carrying the apolipoprotein E 4 allele. Neurology 45, 391.
29. Solomon P. R., Knapp M. J., Gracon S. I., Groccia M. and Pendlebury W. W. (1996) Long-term tacrine treatment in patients with Alzheimer's disease [letter]. Lancet 348, 275-276.
30. Squire L. R. (1987) Memory and Brain. Oxford University Press, New York.
31. Thai L., Fuld P. A., Masur D. M. and Sharpless N. S. (1983) Oral physostigmine and lecithin improve memory in Alzheimer disease. Ann. Neurol. 13, 491-496.
32. Wickelgren W. A. (1975) The long and short term memory. In Short-term Memory, pp. 41-63. Academic, New York.